Moolec Science SA Warrant
Compare this stock
MLECW Stock Report Card
$
10%
Performance
Score:
10/100
MLECW returned -98.16% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.
Profit
Score:
10/100
Out of the last 3 quarters, MLECW has had 0 profitable quarters and has increased their profits year over year on 0 of them.
Volatility
Score:
10/100
MLECW has had a lower than average amount of volatility over the last 12 months giving it a score of 10 of 100.
Moolec Science SA Warrant Summary
Nasdaq / MLECW
Healthcare
Biotechnology
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Checkout Similar Companies
MLECW scored poorly on our reportcard. Here are some similar companies and how they performed.
